Day 3

TUXEDO: stent liberador de paclitaxel no alcanzó la no inferioridad en pacientes diabéticos vs el stent liberador de everolimus.

solaci
solaci
553
0
1_upendra_kaul

Upendra Kaul

Previous article
PLATAFORM: FFR por angiotomografía en pacientes sintomáticos con probabilidad intermedia de enfermedad coronaria.
Next article
LEADERS FREE: Un mes de doble antiagregación parece suficiente en pacientes de alto riesgo de sangrado tratados con el stent liberados de biolimus con polímero bio absorbible.
solaci
solaci

More articles by this author

IN.PACT SFA: Superioridad del balón farmacológico en territorio femoro poplíteo

solaci - 0
Original article John R. Laird Jr

PANDA III: stent liberador de sirolimus con polímero reabsorbible.

solaci - 0
Bo Xu

ISAR-DESIRE 4: Balón liberador de paclitaxel en reestenosis intrastent de un DES.

solaci - 0
Fundamentos: O objetivo desse estudo apresentado na sessão First Report Investigations foi comparar a eficácia anti reestenose da pré-dilatação com scoring balloon versus balão convencional...

LEADERS FREE: Un mes de doble antiagregación parece suficiente en pacientes de alto riesgo de sangrado tratados con el stent liberados de biolimus con...

solaci - 0
Philip M. Urban

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Dr. Andrés Rodríguez - 0
Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Dr. Omar Tupayachi - 0
Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Dr. Juan Manuel Pérez - 0
Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...